Myocardial bridging occurs when a coronary artery takes a deep course within the myocardium of the left ventricle itself. This is thought to be a benign finding not resulting in any clinical ...

The researchers were focused on restoring a critical heart protein called cardiac bridging integrator 1 (cBIN1). They knew ...

Naturally, this TAH is only being tested as a bridge-to-transplant solution, for patients with a failing heart who do not qualify for a ventricular assist device. This may give more heart patients ...

Researchers from Tikkunlev Therapeutics Inc. and the University of Utah have presented preclinical data on TLT-101, a gene therapy consisting of an adeno-associated virus serotype 9 (AAV9) vector ...